Headquartered in Melville, NY, Henry Schein Inc. HSIC is a global leading provider of healthcare products and services. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Presently, Henry Schein serves more than 1 million customers and has operations in 28 countries. The company entered the prestigious Standard & Poor's (S&P) 500 Index in Mar, 2015.Currently, Henry Schein has a Zacks Rank #3 (Hold) but that could change following its impressive first quarter 2016 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:Earnings:The Zacks Consensus Estimate remained steady at $1.39 per share over the last 30 days. Henry Schein’s adjusted earnings per share of $1.41 beat this estimate by 1.4%.Revenues:Henry Schein posted revenues of $2.713 billion, beating the Zacks Consensus Estimate for revenues of $2.658 billion.Key Stats: Revenues derived from Henry Schein’s Dental segment grew 4.1% year over year to $1.3 billion, while Animal Health segment recorded sales of $771.4 million, up 12.7% compared with the prior-year quarter. Revenues from Medical segment increased 21.3% year over year to $538.1million, while sales from Technology and Value-added services segment grew 18.6% to $101.7 million.Major Factors: Henry Schein kick started 2016 on an impressive note, with all four of its operating segments delivering strong year over year growth in the first quarter. Management was particularly upbeat with the double digit growth observed in the company’s adjusted EPS figure. Foreign exchange impact on Henry Schein’s international business was less compares to that in 2015.Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.Check back later for our full write up on this Henry Schein earnings report later!Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HENRY SCHEIN IN (HSIC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research